Skip to main content
VSQTF
OTC Life Sciences

Hydreight Reports Record Q1 Revenue of $24.9M, Up 449%, with $3.3M Adjusted EBITDA

Tom Rudovsky · Reported by PR Newswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.564
Mkt Cap
$58.781M
52W Low
$0.12
52W High
$0.723
52W Position info
371% above low
Off High info
22% below high
Rel. Volume info
6.1× avg
Market data snapshot near publication time

VSQTF has more than doubled off its 52-week low of $0.12 on elevated volume (6.1× avg).

Summary

Hydreight reported its strongest quarter in history for Q1 2026, with record revenue of $24.9 million, representing a 449% year-over-year increase. The company achieved significant profitability, posting $3.3 million in Adjusted EBITDA and $2.6 million in net income. These results highlight substantial operational leverage and rapid scaling of its digital health infrastructure platform. Furthermore, Hydreight significantly strengthened its balance sheet, ending the quarter with $24.2 million in cash and $32.0 million in working capital. This strong financial performance and robust balance sheet position the company well for continued growth and profitability against its full-year guidance.

At the time of this announcement, VSQTF was trading at $0.56 on OTC in the Life Sciences sector, with a market capitalization of approximately $58.8M. The 52-week trading range was $0.12 to $0.72. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

VSQTF - Latest Insights

VSQTF
Jun 01, 2026, 9:32 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.5637
Real-time Price: $0.4776 info
Change: Low Volume info
Market Cap: $49.803M info